Verastem reported $9.6M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alaunos Therapeutics USD 400K 213K Mar/2026
AstraZeneca USD 22.89B 388M Jun/2026
Curis USD 6.74M 1.13M Mar/2026
Cytokinetics USD 24.71M 80.91M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
Incyte USD 1.39B 1.16B Jun/2026
Laboratory Of America USD 688.5M 7.2M Jun/2026
Novartis USD 4.26B 64M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
TG Therapeutics USD 148.84M 41.34M Mar/2026
Verastem USD 9.6M 2.85M Mar/2026